|
Baizhanova Zh.Zh 1, Ignatova T.M. 2, Severova M.M. 1, Burnevich E.Z. 1
Hepatic Steatosis And Insulin Resistance In Chronic Hepatitis C
|
№7 / 2012
|
|
A.F. Verbovoy’, Yu.A. Dolgikh
Hormonal-metabolic Parameters In Young Men With Obesity Manifesting At Puberty
|
№16 / 2011
|
|
A.V. Russkikh
Application Of Thioctic Acid In Nonalcoholic Steatohepatitis
|
№12 / 2011
|
|
Kovalenko LV, Belotserkovtseva LD, Korneeva EV
Clinical Experience With Drug Vitrum Cardio Omega-3 In The Correction Of Metabolic Disorders In Women With Early Menopause
|
№8 / 2011
|
|
A.M. Shilov, A.O. Osia, M.S. Dulayeva, I.V. Yeremina
Pathophysiological Features Of Treatment Of Arterial Hypertension And Disorders Of Carbohydrate Metabolism
|
№5 / 2011
|
|
Shishkova V.N.
Current Approaches To Therapy Type 2 Diabetes – Effect On Insulin Resistance
|
№3 / 2011
|
|
Petunina N.A., Truhina L.V.
Combined Therapy Of Type 2 Diabetes Mellitus
|
№3 / 2011
|
|
Severova M.M., Lopatkina T.N., Russkih A.V., Fomin V.V.
Nonalcoholic Steatohepatitis: Diagnosis And Treatment Based On Risk Factors
|
№2 / 2011
|
|
N.A. Petunina
When To Begin Combined Therapy Of Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
T.Yu. Demidova
Etiopthogenic Role Of Insulin Resistance In The Development Of Metabolic And Vascular Disorders In Type 2 Diabetes Mellitus
|
№16 / 2010
|
|
E.S. Vyuchnova, I.V. Maev, S.M. Babina
Experience Of Use Of Hepabene In The Treatment Of Non-alcoholic Steatohepatitis
|
№12 / 2010
|
|
N.Morkovskikh
Adiponectin And C-reactive Protein As Factors Of Cardiovascular Risk In Men With Type 2 Diabetes Mellitus
|
№8 / 2010
|